These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19947830)

  • 21. Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR).
    Padian NS; Holmes CB; McCoy SI; Lyerla R; Bouey PD; Goosby EP
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):199-203. PubMed ID: 21239991
    [No Abstract]   [Full Text] [Related]  

  • 22. Policy change and micro-politics in global health aid: HIV in South Africa.
    Kavanagh MM; Dubula-Majola V
    Health Policy Plan; 2019 Feb; 34(1):1-11. PubMed ID: 30629158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of external donor support through the U.S. President's Emergency Plan for AIDS Relief on the cost of red cell concentrate in Namibia, 2004-2011.
    Pitman JP; Bocking A; Wilkinson R; Postma MJ; Basavaraju SV; von Finckenstein B; Mataranyika M; Marfin AA; Lowrance DW; Sibinga CT
    Blood Transfus; 2015 Apr; 13(2):240-7. PubMed ID: 25369616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring perceived effects from loss of PEPFAR support for outreach in Kenya and Uganda.
    Qiu M; Paina L; Rodríguez DC; Wilhelm JA; Eze-Ajoku E; Searle A; Zakumumpa H; Ssengooba F; MacKenzie C; Bennett S
    Global Health; 2021 Jul; 17(1):80. PubMed ID: 34273988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond indicators: advances in global HIV monitoring and evaluation during the PEPFAR era.
    Porter LE; Bouey PD; Curtis S; Hochgesang M; Idele P; Jefferson B; Lemma W; Myrick R; Nuwagaba-Biribonwoha H; Prybylski D; Souteyrand Y; Tulli T
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S120-6. PubMed ID: 22797733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the impact of the expanded Mexico City Policy for HIV/ family planning service integration in PEPFAR-supported countries: a risk index.
    Sherwood J; Sharp A; Honermann B; Horrigan C; Chatterjee M; Jones A; Cooney C; Millett G
    BMC Public Health; 2018 Sep; 18(1):1116. PubMed ID: 30208876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.
    Lima VD; Granich R; Phillips P; Williams B; Montaner JS
    J Infect Dis; 2013 Dec; 208(12):2075-84. PubMed ID: 23911712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACTing in Partnership to Accelerate Impact.
    Harrison K; Robinson J; Marks L; Blander J; McDermott P
    J Acquir Immune Defic Syndr; 2018 Aug; 78 Suppl 2():S65-S70. PubMed ID: 29994827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of PEPFAR transition on HIV service delivery at health facilities in Uganda.
    Wilhelm JA; Qiu M; Paina L; Colantuoni E; Mukuru M; Ssengooba F; Bennett S
    PLoS One; 2019; 14(10):e0223426. PubMed ID: 31596884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replicating PEPFAR's success: how interventions shown to be effective abroad can be applied to the AIDS epidemic in the US.
    Fu J; Gavaghan A; Millett G; Walsh T
    Health Aff (Millwood); 2012 Jul; 31(7):1585-92. PubMed ID: 22778349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the President's Emergency Plan for AIDS Relief effect on health systems strengthening in sub-Saharan Africa.
    Cohen RL; Li Y; Giese R; Mancuso JD
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):471-9. PubMed ID: 23254150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.
    Coggin WL; Ryan CA; Holmes CB
    Clin Infect Dis; 2010 May; 50 Suppl 3():S255-9. PubMed ID: 20397956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The President's Emergency Plan for AIDS Relief--is the emergency over?
    El-Sadr WM; Hoos D
    N Engl J Med; 2008 Aug; 359(6):553-5. PubMed ID: 18669420
    [No Abstract]   [Full Text] [Related]  

  • 34. The reach and limits of the US President's Emergency Plan for Aids Relief (PEPFAR) funding of Prevention of Mother-to-Child Transmission (PMTCT) of HIV in Nigeria.
    Ezegbe C; Stephenson N
    Afr J Reprod Health; 2012 Mar; 16(1):23-34. PubMed ID: 22783665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons learned from PEPFAR.
    Dybul M
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S12-3. PubMed ID: 19858928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?
    Coutinho A; Roxo U; Epino H; Muganzi A; Dorward E; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S152-7. PubMed ID: 22797737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of PEPFAR's funding for women and children with HIV/AIDS.
    Kim Y
    Int J Health Plann Manage; 2019 Jan; 34(1):e896-e916. PubMed ID: 30451315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U.S. Government Accountability Office criticizes the PEPFAR.
    Robinson C
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):33-4. PubMed ID: 17373070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
    Venkatesh KK; Mayer KH; Carpenter CC
    Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.